|
|
Volumn 59, Issue 6, 2002, Pages 529-533
|
|
Prevalence and cost savings of therapeutic interchange among U.S. hospitals
a
|
|
Author keywords
Administration; Data collection; Gastrointestinal drugs; Pharmaceutical services; Pharmacoeconomics; Pharmacy, institutional, hospital; Quinolones; Substitution
|
|
Indexed keywords
ANALGESIC AGENT;
ANTACID AGENT;
ANTIINFECTIVE AGENT;
BENZODIAZEPINE DERIVATIVE;
CARDIOVASCULAR AGENT;
CENTRAL NERVOUS SYSTEM AGENTS;
CEPHALOSPORIN DERIVATIVE;
CORTICOSTEROID DERIVATIVE;
DECONGESTIVE AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOLYTIC AGENT;
GASTROINTESTINAL AGENT;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H2 RECEPTOR ANTAGONIST;
HORMONE DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
IRON DERIVATIVE;
LAXATIVE;
MACROLIDE;
OPIATE;
PENICILLIN DERIVATIVE;
POTASSIUM DERIVATIVE;
PROTON PUMP INHIBITOR;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
THIAZIDE DIURETIC AGENT;
THYROID HORMONE;
UNINDEXED DRUG;
VITAMIN;
ARTICLE;
COST CONTROL;
DRUG COST;
HEALTH CARE POLICY;
HEALTH SURVEY;
HOSPITAL COST;
HOSPITAL FINANCE;
PHARMACOECONOMICS;
PREVALENCE;
PRIORITY JOURNAL;
PRIVATE HOSPITAL;
TEACHING HOSPITAL;
UNITED STATES;
|
|
EID: 0037086313
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/59.6.529 Document Type: Article |
|
Times cited : (41)
|
|
References (10)
|
